Schedule 13G ownership disclosure

Freeline Therapeutics Holdings plc

Security class unavailable · CUSIP: 35655L107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,485,656
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001580642-22-000827
Form type
SC 13G/A
Filer
EVENTIDE ASSET MANAGEMENT, LLC
CIK
CIK 1442891
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub